Developing anti-neoplastic biotherapeutics against eIF4F
Crossref DOI link: https://doi.org/10.1007/s00018-016-2430-8
Published Online: 2016-12-21
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Steinberger, Jutta
Chu, Jennifer
Maïga, Rayelle Itoua
Sleiman, Katia
Pelletier, Jerry
Funding for this research was provided by:
Charlotte and Leo Karassik Postdoctoral Fellowship
Canadian Institutes of Health Research (CA) (G243873)
License valid from 2016-12-21